Vedolizumab in the treatment of Crohn’s disease of the pouch

BACKGROUND: Our recent study showed the efficacy and safety of vedolizumab in the treatment of chronic antibiotic-refractory pouchitis. However, there are no published studies on its efficacy and safety in Crohn’s disease (CD) of the pouch. The aim of this study was to assess the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Freeha, Gao, Xian-Hua, Singh, Amandeep, Philpott, Jessica R, Shen, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101609/
https://www.ncbi.nlm.nih.gov/pubmed/30151202
http://dx.doi.org/10.1093/gastro/goy014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101609/
https://www.ncbi.nlm.nih.gov/pubmed/30151202
http://dx.doi.org/10.1093/gastro/goy014

Ejemplares similares